Core Insights - The article discusses the stock buyback activities of various companies, highlighting the total amounts and quantities repurchased, with Tencent Holdings leading the buyback efforts [1][2]. Group 1: Buyback Overview - Tencent Holdings (00700) repurchased 1.051 million shares for a total of 636 million, representing 0.995% of its total share capital [2]. - Xiaomi Group (01810) repurchased 7.2 million shares for 302 million, accounting for 0.430% of its total share capital [2]. - China COSCO Shipping Holdings (01919) repurchased 2.95 million shares for 40.016 million, which is 3.089% of its total share capital [2]. Group 2: Notable Buybacks - Kuaishou Technology (01024) repurchased 462,000 shares for 29.9304 million, representing 0.191% of its total share capital [2]. - Kingsoft Corporation (03888) repurchased 702,800 shares for 19.9994 million, which is 0.580% of its total share capital [2]. - Country Garden Services (06098) repurchased 3 million shares for 18.9615 million, accounting for 1.284% of its total share capital [2]. Group 3: Other Companies - Coolpad Group (02369) repurchased 3.16 million shares for 4.1717 million, representing 7.986% of its total share capital [2]. - China Petroleum & Chemical Corporation (00386) repurchased 764,000 shares for 3.306 million, which is 0.190% of its total share capital [2]. - Mengniu Dairy (02319) repurchased 200,000 shares for 2.9675 million, accounting for 0.762% of its total share capital [2].

Core Viewpoint - Lin Qingxuan is set to go public on the Hong Kong stock market after successfully submitting its prospectus following the listing hearing, aiming to become the first high-end domestic skincare stock and the first domestic essence oil stock in China [2][17]. Financial Performance - Lin Qingxuan's revenue has significantly increased from 691.5 million RMB in 2022 to 1.209641 billion RMB in 2024, with a notable 98.3% year-on-year growth in the first half of 2025, marking its first half-year revenue exceeding 1 billion RMB [3][18]. - The company turned a profit in 2023 with a net profit of 85 million RMB, which further increased to 187 million RMB in 2024, and reached 182 million RMB in the first half of 2025, with net profit margins improving to 10.5%, 15.4%, and 17.3% respectively [4][19]. Product Structure - The core product category for Lin Qingxuan is essence oil, generating revenues of 448 million RMB in 2024 and 478 million RMB in the first half of 2025, accounting for 37% and 45.5% of total revenue respectively [5][20]. - Lin Qingxuan's camellia oil essence has ranked first in retail sales among all facial essence oil products in China for 11 consecutive years since 2014, with cumulative sales exceeding 45 million bottles by June 30, 2025 [7][22]. Sales Channels - Online sales have seen a substantial increase, with revenue rising from 312 million RMB in 2022 to 714 million RMB in 2024, achieving a compound annual growth rate of 51.2%. By the first half of 2025, online revenue reached 688 million RMB, making up 65.4% of total sales [8][23]. - Offline revenue also grew from 378 million RMB in 2022 to 494 million RMB in 2024, with a compound annual growth rate of 14.3%. As of June 30, 2025, Lin Qingxuan operated 554 stores, primarily located in shopping malls [10][25]. Market Position - Lin Qingxuan is positioned as the leading high-end domestic skincare brand in China by retail sales in 2024, and it is part of a broader trend of domestic beauty brands seeking to list in Hong Kong to enhance their capital structure and global competitiveness [11][26]. - The company is among several domestic beauty brands, including Pechoin and Marubi, that have initiated their listing processes in Hong Kong, reflecting a new phase of capitalized development in the industry [14][29].

2025 年 12 月 15 日 投资评级：看好（维持） 商贸零售 行业走势图 《医美化妆品 11 月月报：美丽田园收 购思妍丽 100%股权，双十一大促落幕 美 妆 表 现 亮 眼 — 行 业 点 评 报 告 》 -2025.12.3 11 月社零同比+1.3%，整体增速有所承压 ——行业点评报告 | 黄泽鹏（分析师） | 李昕恬（联系人） | | --- | --- | | huangzepeng@kysec.cn | lixintian@kysec.cn | | 证书编号：S0790519110001 | 证书编号：S0790125100021 | 数据来源：聚源 -36% -24% -12% 0% 12% 24% 2024-12 2025-04 2025-08 商贸零售 沪深300 相关研究报告 《商务部明确零售品质转型，关注永 辉超市调改成效 — 行 业 周 报 》 -2025.12.14 《林清轩更新招股书，关注高端国货 护 肤 公 司 上 市 进 展 — 行 业 周 报 》 -2025.12.7 lixintian@kysec.cn 证书编号：S0790125100021 2025 年 11 月 ...

格隆汇12月15日丨巨子生物(02367.HK)公告，12月15日耗资1391.7万港元回购40万股。 ...

巨子生物(02367)公布，2025年12月15日耗资约1391.73万港元回购40万股股份。 ...

智通财经APP讯，巨子生物(02367)公布，2025年12月15日耗资约1391.73万港元回购40万股股份。 ...

呈交日期： 2025年12月15日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02367 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | 於下列日期開始時的結存(註1) | 2025年12月12日 | 1 ...

Summary of Key Points Core Viewpoint - The article discusses the stock buyback activities of various companies, highlighting the amounts repurchased and their significance in terms of total shares outstanding. Group 1: Major Buybacks - Tencent Holdings (00700) had the largest buyback, repurchasing 1.044 million shares for a total of 636 million [1][2] - China Merchants Industry Holdings (01919) repurchased 4.461 million shares for 60.86 million, representing 2.986% of its total shares [2] - Geely Automobile (00175) bought back 1.362 million shares for 23.92 million, which is 0.078% of its total shares [2] Group 2: Notable Buyback Activities - China Feihe (06186) repurchased 5.655 million shares for 23.18 million, accounting for 2.605% of its total shares [2] - Yum China (09987) conducted two buybacks totaling 58,000 shares for 21.67 million, representing 4.750% of its total shares [2] - Kweichow Moutai (01951) repurchased 772,200 shares for 19.35 million, which is 0.280% of its total shares [2] Group 3: Other Companies Involved - Vitasoy International (00345) repurchased 2,000 shares for 13,300, which is 2.209% of its total shares [3] - Yanzhiyu (01497) bought back 200,000 shares for 1.39 million, representing 0.786% of its total shares [3] - Weigao Group (01066) repurchased 120,000 shares for 631,000, which is 5.179% of its total shares [3]

Investment Rating - Investment rating: Positive (maintained) [1] Core Insights - The report highlights the rapid growth of the emotional economy market, with China's market expected to reach RMB 24.253 trillion in 2024 and grow at a CAGR of 22.2% until 2030, while the global market is projected to reach RMB 14.7 trillion in 2024, with a CAGR of 20.9% [38][43] - The report emphasizes the strong performance of the leading companies in the African hygiene products market, particularly LeShuShi, which has seen significant revenue and profit growth due to cost optimization and market expansion [45][46] - The report discusses the emergence of AI-driven social platforms, such as Soul and MiLian Technology, which are capitalizing on the emotional economy by offering unique user experiences and demonstrating strong financial performance [21][27] Summary by Sections Emotional Economy - The emotional economy is shifting consumer demand from material goods to experiences and emotional fulfillment, with consumers willing to pay for platforms and products that provide joy and stress relief [38] - The emotional economy market in China is expected to grow significantly, with a projected market size of RMB 24.253 trillion by 2024 and a CAGR of 22.2% from 2024 to 2030 [38][41] AI-Driven Social Platforms - Soul, a leading social app targeting Gen Z, reported a revenue of RMB 16.83 billion in the first eight months of 2025, a 17.8% increase year-on-year, with an adjusted net profit of RMB 2.86 billion, reflecting a 73.1% growth [21][23] - MiLian Technology, focusing on a more mature demographic, achieved a revenue of RMB 19.2 billion in the first half of 2025, marking an 85.9% year-on-year increase, with an adjusted net profit of RMB 2.97 billion, up 285% [27][33] African Hygiene Products Market - LeShuShi is the market leader in Africa's hygiene products sector, holding a 20.3% market share in baby diapers and a 15.6% share in sanitary napkins by volume [45] - The company's revenue grew from USD 320 million in 2022 to USD 454 million in 2024, with a CAGR of 19.2%, and its adjusted net profit increased from USD 1.839 million to USD 9.767 million during the same period, achieving a CAGR of 130.5% [45][46] - LeShuShi's product range includes over 340 SKUs, with a focus on multi-brand strategies to cater to various consumer segments [51]

Investment Rating - The report indicates a weak performance in the cosmetics and medical beauty sector, with the Shenwan Beauty Care Index declining by 1.6% from December 5 to December 12, 2025, underperforming the market [3][4]. Core Insights - The cosmetics sector faced pressure in November, with overall GMV in the Taobao system showing weakness due to the pre-promotion of the Double 11 sales event and the rise of Douyin as a sales channel. Brands like Han Shu and Lin Qingxuan maintained stable GMV, while others like Feicui continued to grow significantly [3][9]. - The collagen medical beauty segment is expanding, with two new animal-derived collagen products approved for market entry, expected to drive growth in this area [3][9]. - The report highlights the leading market share of Minoxidil products from Mandi International in the hair loss treatment market, with a steady revenue growth from 982 million yuan in 2022 to approximately 1.455 billion yuan in 2024, reflecting a CAGR of 21.7% from 2022 to 2024 [10][11]. - L'Oréal's acquisition of an additional 10% stake in Galderma, raising its total ownership to 20%, signifies a strategic shift towards the medical beauty and skin health sectors, aiming to adapt to the slowing growth in the Chinese beauty market [3][18]. Summary by Sections Industry Performance - The Shenwan Beauty Care Index and its sub-indices for cosmetics and personal care products have shown declines of 1.2% and 1.7%, respectively, indicating underperformance compared to the Shenwan A Index [4][6]. Key Market Developments - The overall GMV for cosmetics in November was weak, influenced by earlier sales spikes in October and competition from Douyin [9]. - The approval of new collagen products is expected to enhance the supply side of the medical beauty market, with projections for continued expansion in 2026 [9][22]. Company Highlights - Mandi International has maintained a dominant position in the Minoxidil market, with its products accounting for approximately 57% and 71% of the market share in the hair loss treatment and Minoxidil categories, respectively, as of 2024 [11][13]. - The report notes that the Chinese consumer healthcare market is projected to grow from 931.3 billion yuan in 2018 to 16.42 trillion yuan by 2024, with significant growth in hair health and skin health segments [12][13].